Key result
A 52-year-old male with COVID-19 developed biventricular Takotsubo cardiomyopathy that completely resolved prior to hospital discharge.
Case Report (n=1)
No
COVID-19 can precipitate rare biventricular Takotsubo cardiomyopathy, which may fully resolve with supportive care and recovery from the acute viral illness.
Answers are grounded in this paper and cite their sources.
TCM warrants consideration in acute COVID-19 respiratory failure; this Level 5 case leaves open any causal association.
Takotsubo cardiomyopathy (TCM) is a heart failure syndrome characterized by acute and transient dysfunction of the apical segment of the left ventricle. Since the emergence of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the diagnosis of TCM has increased in prevalence. Here we present an intriguing case of a patient who initially presented to the hospital with respiratory failure and received a diagnosis of COVID-19. During the patient's hospital course, he was also diagnosed with biventricular TCM and subsequently experienced complete resolution of TCM before discharge. Providers should be cognizant of the potential cardiovascular complications of COVID-19 and consider those heart failure syndromes, including TCM, could be causing some of the respiratory dysfunction in these patients.
No takes yet. Share an insight, caveat, or question.
Casey et al. (2023) conducted a case report in Biventricular Takotsubo Cardiomyopathy secondary to COVID-19 (n=1). COVID-19 was evaluated. A 52-year-old male with COVID-19 developed biventricular Takotsubo cardiomyopathy that completely resolved prior to hospital discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: